Yutong He

5.7k total citations · 1 hit paper
92 papers, 2.4k citations indexed

About

Yutong He is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yutong He has authored 92 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 32 papers in Surgery and 29 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yutong He's work include Esophageal Cancer Research and Treatment (26 papers), Global Cancer Incidence and Screening (19 papers) and Gastric Cancer Management and Outcomes (14 papers). Yutong He is often cited by papers focused on Esophageal Cancer Research and Treatment (26 papers), Global Cancer Incidence and Screening (19 papers) and Gastric Cancer Management and Outcomes (14 papers). Yutong He collaborates with scholars based in China, United States and Japan. Yutong He's co-authors include You‐Lin Qiao, Di Liang, Wenqiang Wei, Yingsong Lin, Hideo Tanaka, Manami Inoue, Yukari Totsuka, Shogo Kikuchi, Daojuan Li and Wanqing Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Yutong He

88 papers receiving 2.3k citations

Hit Papers

Epidemiology of Esophageal Cancer in Japan and China 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yutong He China 25 1.0k 874 774 695 490 92 2.4k
Behnoush Abedi‐Ardekani France 25 708 0.7× 684 0.8× 526 0.7× 462 0.7× 381 0.8× 48 2.0k
Zhixun Yang China 15 564 0.6× 830 0.9× 647 0.8× 642 0.9× 496 1.0× 21 2.4k
Hecheng Li China 31 1.4k 1.4× 816 0.9× 779 1.0× 1.6k 2.3× 380 0.8× 194 3.3k
Carlo Buonerba Italy 32 646 0.6× 622 0.7× 732 0.9× 1.2k 1.7× 575 1.2× 123 2.7k
Krishna Chaitanya Thandra United States 14 482 0.5× 649 0.7× 645 0.8× 939 1.4× 317 0.6× 20 2.0k
Marcus Cumberbatch United Kingdom 16 1.3k 1.3× 480 0.5× 418 0.5× 399 0.6× 242 0.5× 40 1.9k
Linda M. Dong United States 13 378 0.4× 361 0.4× 806 1.0× 738 1.1× 359 0.7× 14 2.0k
Sandeep Padala United States 10 539 0.5× 532 0.6× 658 0.9× 687 1.0× 263 0.5× 40 1.8k
Jenny N. Poynter United States 25 788 0.8× 804 0.9× 747 1.0× 402 0.6× 744 1.5× 77 2.6k
Xuying Wan China 22 959 1.0× 705 0.8× 307 0.4× 694 1.0× 442 0.9× 36 2.3k

Countries citing papers authored by Yutong He

Since Specialization
Citations

This map shows the geographic impact of Yutong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutong He more than expected).

Fields of papers citing papers by Yutong He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutong He. The network helps show where Yutong He may publish in the future.

Co-authorship network of co-authors of Yutong He

This figure shows the co-authorship network connecting the top 25 collaborators of Yutong He. A scholar is included among the top collaborators of Yutong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutong He. Yutong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qi, et al.. (2025). Multi-module UNet++ for colon cancer histopathological image segmentation. Scientific Reports. 15(1). 28895–28895.
2.
Sun, Yazhou, Xiaoli Wang, Jiahao Feng, et al.. (2025). Multi-omics analysis reveals the crosstalk of epigenetic regulatory networks in cutaneous squamous cell carcinoma progression. Journal of Translational Medicine. 23(1). 1281–1281.
3.
4.
Liang, Di, et al.. (2023). Evaluation of a population-based breast cancer screening in North China. Journal of Cancer Research and Clinical Oncology. 149(12). 10119–10130. 3 indexed citations
5.
6.
Liu, Yanyu, et al.. (2023). Effect of high-level PM2.5 on survival in lung cancer: a multicenter cohort study from Hebei Province, China. Environmental Science and Pollution Research. 30(34). 82094–82106. 4 indexed citations
7.
Shi, Jin, et al.. (2023). Cost-effectiveness evaluation of risk-based breast cancer screening in Urban Hebei Province. Scientific Reports. 13(1). 3370–3370. 2 indexed citations
8.
He, Siyi, He Li, Maomao Cao, et al.. (2022). Survival of 7,311 lung cancer patients by pathological stage and histological classification: a multicenter hospital-based study in China. Translational Lung Cancer Research. 11(8). 1591–1605. 16 indexed citations
9.
Jin, Jing, et al.. (2022). Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency. Frontiers in Oncology. 12. 871483–871483. 13 indexed citations
10.
Li, Daojuan, Jin Shi, Xiao‐Ping Dong, et al.. (2022). Epidemiological characteristics and risk factors of lung adenocarcinoma: A retrospective observational study from North China. Frontiers in Oncology. 12. 892571–892571. 12 indexed citations
11.
Zhang, Xue, et al.. (2021). Research Progress on Epidemiological Trend and Risk Factors of Female Breast Cancer. SHILAP Revista de lepidopterología. 6 indexed citations
12.
He, Yutong, et al.. (2021). The Expression Patterns and Prognostic Value of the Proteasome Activator Subunit Gene Family in Gastric Cancer Based on Integrated Analysis. Frontiers in Cell and Developmental Biology. 9. 663001–663001. 15 indexed citations
13.
He, Yutong, Di Liang, Lingbin Du, et al.. (2020). Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China. Cancer Communications. 40(10). 531–544. 61 indexed citations
14.
15.
He, Yutong, Daojuan Li, Di Liang, et al.. (2018). [Incidence and mortality of bladder cancer in China, 2014].. PubMed. 40(9). 647–652. 21 indexed citations
16.
He, Yutong, et al.. (2015). [Incidence and mortality of cancers appeared in the Hebei provincial cancer registry system in 2011].. PubMed. 36(8). 846–51. 3 indexed citations
17.
Lin, Yingsong, Yukari Totsuka, Yutong He, et al.. (2013). Epidemiology of Esophageal Cancer in Japan and China. Journal of Epidemiology. 23(4). 233–242. 446 indexed citations breakdown →
18.
Chen, Wanqing, Baoen Shan, Rongshou Zheng, et al.. (2012). Analysis of incidence and mortality of leukemia in registration areas of China from 2003 to 2007. Tumori. 32(4). 251–255. 9 indexed citations
19.
Zhao, Deli, Wanqing Chen, Yutong He, et al.. (2011). [A population-based matched case-control study on the risk factors of gastric cardia cancer].. PubMed. 33(10). 775–8. 8 indexed citations
20.
Chen, Wanqing, et al.. (2011). [Analysis of risk factors for upper gastrointestinal cancer in China: a multicentric population-based case-control study].. PubMed. 45(3). 244–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026